Literature DB >> 35582168

Kidney Injury in Patients Treated with Immune Checkpoint Inhibitors Does Not Meet KDIGO-AKI Criteria.

Maartje F A Verploegen1, Marye J Boers-Sonderen2, Berber Piet3, Jack F M Wetzels1.   

Abstract

Kidney injury in patients treated with immune checkpoint inhibitors develops gradually and often does not meet the Kidney Disease Improving Global Outcomes criteria for AKI.Proper classification of kidney injury could prevent the development of CKD and improve continued oncologic treatment.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  KDIGO; acute kidney injury; clinical nephrology; immune checkpoint inhibitors

Mesh：

Substances：

Year:  2021        PMID： 35582168      PMCID： PMC9034820          DOI： 10.34067/KID.0006752021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


  11 in total

1.  Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study.

Authors:  M Espi; C Teuma; E Novel-Catin; D Maillet; P J Souquet; S Dalle; L Koppe; D Fouque
Journal:  Eur J Cancer       Date:  2021-02-16       Impact factor: 9.162

Review 2.  Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020.

Authors:  Shruti Gupta; Frank B Cortazar; Leonardo V Riella; David E Leaf
Journal:  Kidney360       Date:  2020-01-14

3.  Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.

Authors:  Sandhya Manohar; Ranine Ghamrawi; Madhuri Chengappa; Busra N Bacik Goksu; Lisa Kottschade; Heidi Finnes; Roxana Dronca; Konstantinos Leventakos; Joerg Herrmann; Sandra M Herrmann
Journal:  Kidney360       Date:  2020-01-07

4.  The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.

Authors:  Harish Seethapathy; Sophia Zhao; Donald F Chute; Leyre Zubiri; Yaa Oppong; Ian Strohbehn; Frank B Cortazar; David E Leaf; Meghan J Mooradian; Alexandra-Chloé Villani; Ryan J Sullivan; Kerry Reynolds; Meghan E Sise
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-31       Impact factor: 8.237

5.  Acute kidney injury in patients treated with anti-programmed death receptor-1 for advanced melanoma: a real-life study in a single-centre cohort.

Authors:  Claire Stein; Stéphane Burtey; Julien Mancini; Marion Pelletier; Marion Sallée; Philippe Brunet; Philippe Berbis; Jean Jacques Grob; Stéphane Honoré; Caroline Gaudy; Noémie Jourde-Chiche
Journal:  Nephrol Dial Transplant       Date:  2021-08-27       Impact factor: 5.992

6.  Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.

Authors:  Marije S Koks; Gurbey Ocak; Britt B M Suelmann; Cornelia A R Hulsbergen-Veelken; Saskia Haitjema; Marieke E Vianen; Marianne C Verhaar; Karin A H Kaasjager; Meriem Khairoun
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

7.  Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes.

Authors:  Alejandro Meraz-Muñoz; Eitan Amir; Pamela Ng; Carmen Avila-Casado; Claire Ragobar; Christopher Chan; Joseph Kim; Ron Wald; Abhijat Kitchlu
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

8.  Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience.

Authors:  Omar Mamlouk; Umut Selamet; Shana Machado; Maen Abdelrahim; William F Glass; Amanda Tchakarov; Lillian Gaber; Amit Lahoti; Biruh Workeneh; Sheldon Chen; Jamie Lin; Noha Abdel-Wahab; Jean Tayar; Huifang Lu; Maria Suarez-Almazor; Nizar Tannir; Cassian Yee; Adi Diab; Ala Abudayyeh
Journal:  J Immunother Cancer       Date:  2019-01-06       Impact factor: 13.751

9.  Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.

Authors:  Frank B Cortazar; Zoe A Kibbelaar; Ilya G Glezerman; Ala Abudayyeh; Omar Mamlouk; Shveta S Motwani; Naoka Murakami; Sandra M Herrmann; Sandhya Manohar; Anushree C Shirali; Abhijat Kitchlu; Shayan Shirazian; Amer Assal; Anitha Vijayan; Amanda DeMauro Renaghan; David I Ortiz-Melo; Sunil Rangarajan; A Bilal Malik; Jonathan J Hogan; Alex R Dinh; Daniel Sanghoon Shin; Kristen A Marrone; Zain Mithani; Douglas B Johnson; Afrooz Hosseini; Deekchha Uprety; Shreyak Sharma; Shruti Gupta; Kerry L Reynolds; Meghan E Sise; David E Leaf
Journal:  J Am Soc Nephrol       Date:  2020-01-02       Impact factor: 10.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.